Trial intelligence / Profile preview

Evaluation of the effect of metformin + alpha-lipoic acid combination in prediabetes

IRCT20240501061620N2Phase 3Completed

Sponsor
Semnan University of Medical Sciences
Start
Mar 2025
Modality
Small Molecules
Countries
1
01

Overview

Phase 3 trial of metformin and alpha-lipoic acid in prediabetes, sponsored by Semnan University of Medical Sciences. Started Mar 2025; status: completed.

02

Drugs

metforminalpha-lipoic acid
03

Conditions

prediabetes

Beyond the preview

Go deeper on IRCT20240501061620N2.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20240501061620N2.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call